PMV Pharmaceuticals, Inc. cotiza a 1.41 USD y tiene una capitalización bursátil de $106M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor a…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.34 | $-0.34 |
| Estimado | $-0.34 | $-0.40 | $-0.38 | $-0.39 |
| Sorpresa | — | — | +10.5% | +12.8% |
| Métrica | PMVP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -74.2% | -40.4% | -33.8% |
| ROA | -66.7% | -32.0% | -34.7% |
| Current Ratio | 10.09 | 2.84 | +7.25 |
| Debt / Equity | — | 0.28 | — |